Form 8-K Theravance Biopharma, For: Nov 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Theravance Biopharma (TBPH) Tops Q3 EPS by 4c
November 9, 2015 5:06 PM ESTTheravance Biopharma (NASDAQ: TBPH) reported Q3 EPS of ($1.40), $0.04 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $10.7 million versus the consensus estimate of $4.24 million.
For earnings history and earnings-related data on Theravance Biopharma (TBPH) click here.
... More